The Effect of the Transversus Abdominis Plane Block to Postoperative Analgesia for Cesarean Section (TAP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03634111 |
Recruitment Status :
Completed
First Posted : August 16, 2018
Last Update Posted : August 16, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obstetric Pain | Procedure: TAP block Drug: Morphine Drug: Ropivacaine | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | Transversus abdominis plane block under the ultrasound guidance |
Masking: | None (Open Label) |
Masking Description: | Participants were cesarean section with general anesthesia |
Primary Purpose: | Other |
Official Title: | The Transversus Abdominis Plane Block |
Actual Study Start Date : | July 10, 2017 |
Actual Primary Completion Date : | July 15, 2017 |
Actual Study Completion Date : | March 31, 2018 |

Arm | Intervention/treatment |
---|---|
Active Comparator: T group
The TAP block group was called T group. The participants were performed TAP block under guidance at the end of surgery.
|
Procedure: TAP block
TAP block was performed under guidance with 0.25% ropivacaine 20 ml each side.
Other Name: Transversus abdominis plane block Drug: Morphine Single dose was 1 mg. The locked time was 6 minutes. The limited dose was 40 mg/ 4 giờ.
Other Name: Opioids Drug: Ropivacaine Ropivacaine 0.25% 20 ml each side
Other Name: Anaropin |
Placebo Comparator: C group
The controlled group was called C group. The participants has not TAP block and were treated postoperative analgesia with intravenous morphine to patients controlled analgesia
|
Drug: Morphine
Single dose was 1 mg. The locked time was 6 minutes. The limited dose was 40 mg/ 4 giờ.
Other Name: Opioids Drug: Ropivacaine Ropivacaine 0.25% 20 ml each side
Other Name: Anaropin |
- Total morphine consumption during 24 hours [ Time Frame: 24 hours ]Morphine was intravenous perfusion to participants during 24 hours with patients controlled analgesia (PCA).
- The time required the first of dose of morphine (hours) [ Time Frame: 24 hours ]The time was from the end of surgery to the participants required the first of dose of morphine with PCA.
- Pain score: VAS [ Time Frame: 24 hours ]Pain score was measured with visual analogue scale (VAS). VAS is from 0 to 10. The zero is complete non-pain and the ten is severe pain
- The rate of complications of TAP block [ Time Frame: 24 hours ]There were rate of systemic toxicity, puncture peritonea, and hematomae in abdominal wall
- The rate of side effect of morphine [ Time Frame: 24 hours ]There were rate of sedation, respiratory failure, nause and vomiting, pruritus
- The satisfaction of participants: Likert [ Time Frame: 24 hours ]It was evaluated with Linkert score. Likerk score is from 1 to 5: 1-strongly disagree, 2-disagree, 3-neither agree nor disagree, 4-agree, 5-strongly agree

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Cesarean section with general anesthesia.
- The ASA classification was from II to III
Exclusion Criteria:
- The acute fetal impairment.
- The severe live or renal failure.
- Tolerance opioids

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03634111
Vietnam | |
THANG Nguyen Trong | |
Ho Chi Minh, Vietnam, 700000 |
Principal Investigator: | THANG T Nguyen, Mr | Gia Dinh People Hospital |
Responsible Party: | Gia Dinh People Hospital |
ClinicalTrials.gov Identifier: | NCT03634111 |
Other Study ID Numbers: |
11-2017/CN-HĐĐĐ |
First Posted: | August 16, 2018 Key Record Dates |
Last Update Posted: | August 16, 2018 |
Last Verified: | August 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
transversus abdominis plane block (TAP block) postoperative analgesia cesarean section |
Labor Pain Pain Neurologic Manifestations Morphine Ropivacaine Analgesics, Opioid Narcotics |
Central Nervous System Depressants Physiological Effects of Drugs Analgesics Sensory System Agents Peripheral Nervous System Agents Anesthetics, Local Anesthetics |